The European Commission (EC) purchased an additional 200 million doses of the Pfizer and BioNTech vaccine Comirnaty to distribute in the 27 European Union member states in 2021. This means the commission has committed to ordering a total of 500 million doses that will be delivered in 2021. The commission has the option to request a supply of an additional 100 million doses in the future.

Additionally, the EC purchased an additional 150 million doses of the COVID-19 vaccine from Moderna, which are scheduled to be delivered in the third and fourth quarters of 2021. This means the commission has committed to ordering a total of 310 million doses that will be delivered in 2021. The deal gives the commission the option to purchase an additional 150 million doses to be delivered in 2022.

U.S. commits to additional 100M Moderna COVID-19 vaccine doses
The U.S. government has purchased an additional 100 million doses of Moderna's COVID-19 vaccine.

U.S. opts for 100M more doses of Pfizer-BioNTech COVID-19 vaccine
The U.S. government has exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine

EC authorizes Moderna's COVID-19 vaccine
The European Commission (EC) has granted a conditional marketing authorization for Moderna's messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273. The authorization...

EC authorizes Pfizer, BioNTech COVID-19 vaccine
The European Commission (EC) has granted a conditional marketing authorization to Pfizer and BioNTech for their COVID-19 vaccine.

Pfizer, BioNTech get positive CHMP recommendation for COVID-19 vaccine
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion to recommend the conditional...